Mersana Therapeutics Inc (MRSN) — Long-term Investment Intensity

Latest as of December 2017: 8.0%

Mersana Therapeutics Inc (MRSN) has a Long-term Investment Intensity of 8.0% as of December 2017. Long-term investments of $10.48 Million represent 8.0% of total assets of $130.72 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Mersana Therapeutics Inc (MRSN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

8.0%
LT Investments / Total Assets

Long-term Investments

$10.48 Million
USD

Total Assets

$130.72 Million
USD

Country

USA
NASDAQ

Mersana Therapeutics Inc Long-term Investment Intensity (2017–2017)

This chart shows how Mersana Therapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of December 2017, the intensity stands at 8.0%, reflecting long-term investments of $10.48 Million against total assets of $130.72 Million USD. Explore Mersana Therapeutics Inc (MRSN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Mersana Therapeutics Inc (2017–2017)

The table below presents the year-by-year Long-term Investment Intensity for Mersana Therapeutics Inc from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see MRSN market cap.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2017 8.0% $10.48 Million $130.72 Million
pp = percentage points